University Hospitals OBGYN and urologist Joseph Welles Henderson, MD, named InterStim™ Center of Excellence
Recognized for superiority in incontinence care for patients
2024-01-22
(Press-News.org) CLEVELAND -- Joseph Welles Henderson, MD, of University Hospitals has been named an InterStim™ Center of Excellence by Medtronic (NYSE: MDT), the world’s largest medical device manufacturer. The designation is awarded to caregivers who have demonstrated particular expertise in the use of the InterStim™ system to treat overactive bladder, as well as non-obstructive urinary retention and chronic fecal incontinence.
Dr. Henderson is an OBGYN and urologist, and specializes in female pelvic medicine and reconstruction surgery. According to the National Association for Continence, more than 60 million Americans live with incontinence, and many of them don’t realize that their condition may be treatable.
Of those patients who seek treatment, many choose the InterStim™ system. This technology delivers relief by gently stimulating the patient’s sacral nerves through a small device implanted in the lower back. In the 25 years since its introduction, it has been used by more than 375,000 patients worldwide.
“I’m incredibly proud to have been recognized by Medtronic for excellence in treating patients with incontinence,” said Dr. Henderson. “It’s important that patients dealing with incontinence know it’s very common, and is not just a normal part of aging. There are a number of potential surgical and non-surgical treatment options we can discuss together and find the best solution.”
Receiving the Center of Excellence designation is a noteworthy accomplishment in the field. Through a highly selective process, Medtronic identifies practices that are particularly proficient in the placement of the InterStim™ system, reviewing such factors as the number of procedures performed, patient satisfaction, outcomes and more.
###
About University Hospitals / Cleveland, Ohio
Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 21 hospitals (including five joint ventures), more than 50 health centers and outpatient facilities, and over 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship quaternary care, academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Northeast Ohio Medical University, Oxford University, the Technion Israel Institute of Technology and National Taiwan University College of Medicine. The main campus also includes the UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with more than 3,000 active clinical trials and research studies underway. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to 19 Clinical Care Delivery and Research Institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit UHhospitals.org.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-01-22
SAN ANTONIO, Jan. 22, 2024 — A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported.
The researchers, working with colleagues from The University of California, Davis, and Boston University, conducted an MRI brain imaging study published ...
2024-01-22
Qiang Zeng, Associate Professor, Computer Science, received funding for the project: "Towards Lifetime Supply Chain Security for Internet of Things: Testing an Update Before Trusting It."
The global Internet of Things (IoT) market size is expected to rise substantially by 2029. IoT devices are manufactured by various companies around the world, and thus, should not be trusted by default. Zeng aims to ensure lifetime supply chain security of IoT devices. To attain this objective, he is proposing to test an IoT device and every firmware update through ...
2024-01-22
Md Tanvir Arafin, Assistant Professor, Cybersecurity Engineering, received funding for the project: "Securing Chiplet-based Semiconductor Manufacturing from Untrusted Supply Chains."
Monolithic integrated circuit (IC) design is reaching the physical limit to accommodate the ever-increasing demand of cramming more transistors in a chip. To address this, novel design primitives that move from monolithic design practices to heterogeneous integration of IC primitives in a 2.5 or 3D structure have emerged. ...
2024-01-22
Low back pain is a major cause of disability around the globe, with more than 570 million people affected. In the United States alone, health care spending on low back pain was $134.5 billion between 1996 and 2016, and costs are increasing.
"The good news is that most episodes of back pain recover, and this is the case even if you have already had back pain for a couple of months," University of South Australia Professor Lorimer Moseley says.
"The bad news is that once you have had back pain for more than a few months, the chance ...
2024-01-22
Organic mixed ionic–electronic conductors (OMIECs) are a highly sought-after class of materials for non-conventional applications, such as bioelectronics, neuromorphic computing, and bio-fuel cells, owing to their two-in-one electronic and ionic conduction properties. To ensure a much wider acceptance of these fascinating materials, there is a need to diversify their properties and develop techniques that allow application-specific tailoring of the features of OMIEC-based devices. A crucial aspect of this process is to develop strategies for evaluating the various properties of these ...
2024-01-22
SPOKANE, Wash. – Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate. The discovery opens the door to new treatment strategies that could overcome this resistance. This could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men.
Led by a team of scientists at Washington State University, ...
2024-01-22
About The Study: The findings of this study of 398,000 UK Biobank participants support the improvement of social isolation and loneliness in people with obesity to decrease obesity-related excess risk of mortality.
Authors: Lu Qi, M.D., Ph.D., of the Tulane University School of Public Health and Tropical Medicine in New Orleans, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.52824)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...
2024-01-22
About The Study: The results of this study including 2,261 and 1,940 infants ages 12 and 18 months, respectively, suggest that COVID-19 vaccination was safe during pregnancy from the perspective of infant neurodevelopment to 18 months of age. Additional longer-term research should be conducted to corroborate these findings and buttress clinical guidance with a strong evidence base.
Authors: Eleni G. Jaswa, M.D., M.Sc., of the University of California, San Francisco, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2023.5743)
Editor’s ...
2024-01-22
Key takeaways:
A new 3D-printable material called “supramolecular ink” replaces costly scarce metals with inexpensive, Earth-abundant materials.
The organic material requires far less energy to manufacture than conventional methods.
It could also enhance the sustainability of 3D-printable wearable devices, lighting technologies, and luminescent art and sculpture.
A research team led by Lawrence Berkeley National Laboratory (Berkeley Lab) has developed “supramolecular ink,” a new technology for use in OLED (organic light-emitting ...
2024-01-22
Commencing in January, the Urban Future Lab (UFL) at the NYU Tandon School of Engineering, in collaboration with Greentown Labs, will serve as the supportive entry point in the U.S. for the fourth cohort of Innovate UK’s Global Incubator Programme: Clean Growth edition. This initiative is specifically designed to foster and assist the establishment of innovative climate technology companies demonstrating significant potential for international scalability into new markets.
The annual program extends the opportunity to eight U.K.-based businesses, enabling them to explore the U.S. market and gain access to esteemed mentors over a six-month period.
"We’re ...
LAST 30 PRESS RELEASES:
[Press-News.org] University Hospitals OBGYN and urologist Joseph Welles Henderson, MD, named InterStim™ Center of Excellence
Recognized for superiority in incontinence care for patients
